Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor
Glucotrack (NASDAQ:GCTK) on Tuesday reported the successful completion of its first in human clinical study, sending shares up ~60% in the morning trade. This study represents first real-time, ...
Nasdaq19d
Glucotrack, Inc. Announces Successful Completion of First Human Clinical Study for Continuous Blood Glucose Monitoring Technology
Glucotrack, Inc. has announced the successful completion of its first human clinical study for a continuous blood glucose monitor (CBGM), which is uniquely placed in the subclavian vein for real ...
HME News16d
Glucotrack completes first human clinical study for CBGM
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.